Citadel delivers strong growth in key market segments
Name: Citadel Group Limited (ASX:CGL)
Market Capitalisation: $334 million
Opening Share Price: $6.80
Citadel Group Limited (ASX:CGL) has delivered another record full year profit in fiscal 2018.
The net profit of $19.4 million represented earnings per share of 32.5 cents, implying growth of 35.4 cents compared with fiscal 2017.
This was slightly above consensus forecasts of 34.5 cents.
Management declared a final dividend of 9 cents, bringing the full year dividend to 13.8 cents, in line with consensus forecasts.
Record contract wins underpinned the result and extensions totalling $74 million were achieved across the group’s core market segments of national security, defence, e-health, government and tertiary education.
Citadel specialises in managing information in complex environments through integrating systems and people to provide information.
Revenues supported by long term contracts
The majority of Citadel’s revenues are derived from long term managed services and software-as-a-service solutions.
Having made investments to cloud-enable its software, the company sees itself as well positioned to scale these solutions and drive further growth.
This is particularly the case in relation to the Citadel Information Exchange (Citadel–IX) solution which, in less than 12 months, has seen 10 new clients signed up to long term contracts, and additionally generated more than $68 million in new SaaS opportunities.
However, this does remain a speculative stock and investors should seek professional financial advice if considering this stock for their portfolio.
While management didn’t provide quantitative guidance, it expects a record sales pipeline, a portfolio of top tier clients and scalable cloud enabled IT solutions to drive earnings in fiscal 2019 and beyond.
Consensus forecasts point to earnings per share of 34.1 cents in fiscal 2019, implying a PE multiple of circa 20, a significant discount to the industry group average of 29.
The consensus 12 month price target which was only updated a fortnight ago is $7.39
This article is General Information and contains only some information about some elements of one or more financial products. It may contain; (1) broker projections and price targets that are only estimates and may not be met, (2) historical data in terms of earnings performance and/or share trading patterns that should not be used as the basis for an investment as they may or may not be replicated. Those considering engaging with any financial product mentioned in this article should always seek independent financial advice from a licensed financial advisor before making any financial decisions.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.